Opioid Scandal Haunts Drug Companies As They Respond To Pandemic

August 10, 2020

Brian Mann, IdeaStream

Purdue Pharma, with headquarters in downtown Stamford, Conn., was forced into bankruptcy last year by the opioid crisis. As drug firms race to position themselves as key players in the coronavirus fight, the industry faces a renewed wave of civil lawsuits stemming from its role in the nation's deadly opioid epidemic. [Drew Angerer / Getty Images]

As drug firms race to position themselves as key players in the coronavirus fight, the industry faces a renewed wave of civil lawsuits stemming from its role in the nation's deadly opioid epidemic.

Thousands of cases that ground to a halt because of the COVID-19 pandemic are moving forward again as local, state and federal courts reopen around the U.S.